This site is currently implementing core features and is not ready for patient use yet.
This site is currently implementing core features and is not ready for patient use yet.
French-Austrian vaccine company specializing in travel and endemic disease vaccines.
Valneva, formed in 2012 from Intercell and Vivalis, focuses on vaccines for infectious diseases including cholera, Lyme disease, chikungunya, and others, with manufacturing in Europe.
No FAQ items available.